Gemini Genomics

NGS Sequencing

bms-564,929

BMS-303141
B1079-25 25 mg
EUR 247.00
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141
B1079-5.1 10 mM (in 1mL DMSO)
EUR 134.00
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141
B1079-50 50 mg
EUR 398.00
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-794833
B1438-10 10 mg
EUR 253.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833
B1438-5 5 mg
EUR 164.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833
B1438-5.1 10 mM (in 1mL DMSO)
EUR 177.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833
B1438-50 50 mg
EUR 833.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833
B1438-S Evaluation Sample
EUR 81.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-378806
B1533-10 10 mg
EUR 305.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806
B1533-100 100 mg
EUR 1186.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806
B1533-5 5 mg
EUR 189.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806
B1533-5.1 10 mM (in 1mL DMSO)
EUR 235.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806
B1533-50 50 mg
EUR 838.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-626529
B1557-25
EUR 805.00

BMS-626529
B1557-5
EUR 240.00

BMS-708163
B1622-25
EUR 805.00

BMS-708163
B1622-5
EUR 240.00

BMS-833923
9547-25
EUR 544.00

BMS-833923
9547-5
EUR 175.00

BMS-299897
9606-25
EUR 675.00

BMS-299897
9606-5
EUR 207.00

BMS-707035
A4069-10 10 mg
EUR 195.00
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035
A4069-100 100 mg
EUR 885.00
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035
A4069-5 5 mg
EUR 131.00
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035
A4069-50 50 mg
EUR 560.00
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-911543
A4152-10 10 mg
EUR 400.00
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543
A4152-25 25 mg
EUR 595.00
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543
A4152-5 5 mg
EUR 244.00
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543
A4152-50 50 mg
EUR 827.00
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS 299897
A4400-10 10 mg
EUR 277.00
Description: BMS-299897 is a selective inhibitor of ?-secretase with IC50 value of 12 nM [1]. ?-secretase is an intergral membrane protein whose well-known substrate is amyloid precursor protein and involves in the process of cleaving single-pass transmembrane proteins at residues with the transmembrane domain.

BMS 299897
A4400-5.1 10 mM (in 1mL DMSO)
EUR 300.00
Description: BMS-299897 is a selective inhibitor of ?-secretase with IC50 value of 12 nM [1]. ?-secretase is an intergral membrane protein whose well-known substrate is amyloid precursor protein and involves in the process of cleaving single-pass transmembrane proteins at residues with the transmembrane domain.

BMS 299897
A4400-50 50 mg
EUR 693.00
Description: BMS-299897 is a selective inhibitor of ?-secretase with IC50 value of 12 nM [1]. ?-secretase is an intergral membrane protein whose well-known substrate is amyloid precursor protein and involves in the process of cleaving single-pass transmembrane proteins at residues with the transmembrane domain.

BMS-509744
A3250-10 10 mg
EUR 412.00
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-509744
A3250-5 5 mg
EUR 284.00
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-509744
A3250-50 50 mg
EUR 1678.00
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-626529
A3253-10 10 mg
EUR 340.00
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529
A3253-200 200 mg
EUR 1790.00
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529
A3253-5 5 mg
EUR 224.00
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529
A3253-50 50 mg
EUR 920.00
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-663068
A3254-5 5 mg
EUR 300.00
Description: BMS-663068 is a small-molecule attachment inhibitor of HIV-1 gp120 with IC50 value of [1].The first step of HIV-1 virus to entry host cells is the binding of the viral gp120 envelope glycopeptide to the CD4 receptor of host cell.

BMS-663068
A3254-5.1 10 mM (in 1mL DMSO)
EUR 398.00
Description: BMS-663068 is a small-molecule attachment inhibitor of HIV-1 gp120 with IC50 value of [1].The first step of HIV-1 virus to entry host cells is the binding of the viral gp120 envelope glycopeptide to the CD4 receptor of host cell.

BMS-690514
A3256-10 10 mg
EUR 693.00
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514
A3256-5 5 mg
EUR 450.00
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514
A3256-5.1 10 mM (in 1mL DMSO)
EUR 400.00
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514
A3256-50 50 mg
EUR 1703.00
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-833923
A3258-10 10 mg
EUR 131.00
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923
A3258-5 5 mg
EUR 102.00
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923
A3258-5.1 10 mM (in 1mL DMSO)
EUR 167.00
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923
A3258-50 50 mg
EUR 282.00
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-927711
A3259-10 10 mg
EUR 628.00
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711
A3259-100 100 mg
EUR 3850.00
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711
A3259-5 5 mg
EUR 376.00
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711
A3259-50 50 mg
EUR 2222.00
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-536924
A2238-10 10 mg
EUR 247.00
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924
A2238-5 5 mg
EUR 166.00
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924
A2238-5.1 10 mM (in 1mL DMSO)
EUR 258.00
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924
A2238-50 50 mg
EUR 920.00
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-777607
A5703-100 100 mg
EUR 838.00
Description: BMS 777607 is a novel, selective and orally available ATP-competitive MET kinase inhibitor that primarily targets several MET family members, including RON, MET, Tyro-3 and AxI.

BMS-777607
A5703-25 25 mg
EUR 340.00
Description: BMS 777607 is a novel, selective and orally available ATP-competitive MET kinase inhibitor that primarily targets several MET family members, including RON, MET, Tyro-3 and AxI.

BMS-777607
A5703-5 5 mg
EUR 142.00
Description: BMS 777607 is a novel, selective and orally available ATP-competitive MET kinase inhibitor that primarily targets several MET family members, including RON, MET, Tyro-3 and AxI.

BMS-777607
A5703-5.1 10 mM (in 1mL DMSO)
EUR 148.00
Description: BMS 777607 is a novel, selective and orally available ATP-competitive MET kinase inhibitor that primarily targets several MET family members, including RON, MET, Tyro-3 and AxI.

BMS-777607
A5703-S Evaluation Sample
EUR 81.00
Description: BMS 777607 is a novel, selective and orally available ATP-competitive MET kinase inhibitor that primarily targets several MET family members, including RON, MET, Tyro-3 and AxI.

BMS-754807
A1185-100 100 mg
EUR 862.00
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807
A1185-25 25 mg
EUR 340.00
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807
A1185-5 5 mg
EUR 125.00
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807
A1185-5.1 10 mM (in 1mL DMSO)
EUR 154.00
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-599626
1614-1
EUR 213.00

BMS-599626
1614-5
EUR 615.00

BMS-777607
2455-25
EUR 566.00

BMS-777607
2455-5
EUR 185.00

BMS-911543
2630-1
EUR 142.00

BMS-911543
2630-5
EUR 414.00

BMS-754807
2631-1
EUR 131.00

BMS-754807
2631-5
EUR 370.00

BMS-303141
2821-10
EUR 207.00

BMS-303141
2821-50
EUR 686.00

Bms 626529
20-abx182383
  • EUR 1720.00
  • EUR 620.00
  • 100 mg
  • 10 mg
  • Shipped within 1-2 weeks.

BMS-817378
B5862-10 10 mg
EUR 311.00
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378
B5862-5 5 mg
EUR 189.00
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378
B5862-50 50 mg
EUR 833.00
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-582949
B6187-1 1 mg
EUR 145.00
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949
B6187-25 25 mg
EUR 777.00
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949
B6187-5 5 mg
EUR 290.00
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS 191011
B7146-10 10 mg
EUR 232.00
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011
B7146-25 25 mg
EUR 483.00
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011
B7146-5 5 mg
EUR 145.00
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011
B7146-50 50 mg
EUR 818.00
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 193885
B7327-10 10 mg
EUR 454.00
Description: BMS-193885 is a potent and selective neuropeptide Y1 receptor antagonist with IC50 of 5.9nM.Neuropeptide Y receptor 1 is G-protein coupled receptors and implicated in the modulation of food intake and energy homeostasis.

BMS 193885
B7327-50 50 mg
EUR 1714.00
Description: BMS-193885 is a potent and selective neuropeptide Y1 receptor antagonist with IC50 of 5.9nM.Neuropeptide Y receptor 1 is G-protein coupled receptors and implicated in the modulation of food intake and energy homeostasis.

BMS 453
B7396-10 10 mg
EUR 270.00
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids.